Table 1.
Association of NUDT21 expression with clinicopathological features in gastric cancer patients.
| Parameter | NUDT21 expression [n (%)] | P | χ2 | ||
|---|---|---|---|---|---|
| n | Negative | Positive | |||
| Age (years) | |||||
| ≤60 | 32 | 11 (34.4) | 21 (65.6) | 0.830 | 0.046 |
| >60 | 38 | 14 (36.8) | 24 (63.2) | ||
| Gender | |||||
| male | 39 | 13 (33.3) | 26 (66.7) | 0.641 | 0.217 |
| female | 31 | 12 (38.7) | 19 (61.3) | ||
| Tumor size (cm) | |||||
| ≤5 | 43 | 20 (46.5) | 23 (53.5) | 0.017 | 5.661 |
| >5 | 27 | 5 (18.5) | 22 (81.5) | ||
| Lymph node metastasis | |||||
| No | 24 | 13 (54.2) | 11 (45.8) | 0.020 | 5.416 |
| Yes | 46 | 12 (26.1) | 34 (73.9) | ||
| Grade | |||||
| I-II | 43 | 18 (41.9) | 25 (58.1) | 0.176 | 1.834 |
| III | 27 | 7 (25.9) | 20 (74.1) | ||
| Stage | |||||
| I-II | 22 | 13 (59.1) | 9 (40.9) | 0.006 | 7.636 |
| III-IV | 48 | 12 (25.0) | 36 (75.0) | ||